Ashley Marie Campbell

Interests

Research

Integration of pharmacists into various models of geriatric care, best practices for anticoagulation in older adults, medication safety in older adults, aging/healthspan, scholarship of teaching and learning, preparing an age-friendly workforce

Teaching

Educational psychology (particularly cognitive load optimization and learner motivation), innovative active learning strategies, interprofessional education, case-based teaching and learning

Courses

Scholarly Contributions

Chapters

• Campbell, A. M. (2023). Urinary Incontinence. In Pharmacotherapy Principles and Practice Study Guide. McGraw-Hill.
• Campbell, A. M. (2020). Chronic Kidney Disease: Progression Prevention. In Pharmacotherapy Principles and Practice Study Guide: A Case-Based Care Plan Approach. McGraw-Hill.

Journals/Publications

• Antwi, P. B., Warholak, T., Davis, L., & Campbell, A. M. (2026). Reliability and Validity of an Abbreviated Motivated Strategies for Learning Questionnaire in Student Pharmacists. American Journal of Pharmaceutical Education, 90(Issue 4). doi:10.1016/j.ajpe.2026.101958
  More info

  Objective The study examined the psychometric properties of a modified version of the Motivated Strategies for Learning Questionnaire (MSLQ) among a cohort of student pharmacists using the Rasch rating scale model. Methods The modified MSLQ consisted of 51 self-report questions (items) assessing 4 motivation-based domains and 5 learning strategy domains. The assessed domains consisted of 3 to 12 items per domain and were scored on a 7-point Likert scale, ranging from 1 (“not at all true of me”) to 7 (“very true of me”). MSLQ data for 66 students were evaluated in Winsteps (Version 5.6.0, Portland, Oregon), where the Rasch rating scale model was selected to ascertain the instrument’s validity, scale performance, and reliability. Results All 9 domains were unidimensional and measured a unidimensional construct of interest, but the 7-point Likert scale did not function optimally and needed to be adjusted for all domains except self-efficacy for learning and performance. Acceptable estimates of reliability coefficients (Cronbach’s alpha) were observed for all domains, but the person-item maps indicated a mismatch between the instrument’s item difficulty and students’ ability levels. Conclusion An adjusted 4-point Likert scale is suggested for the extrinsic goal orientation, elaboration, organization, test anxiety, and cognitive and metacognitive learning strategies domains. Items at the same difficulty levels for the elaboration, extrinsic goal orientation, peer learning, self-efficacy, organization, cognitive and metacognitive learning strategies, and test anxiety domains should be considered for removal, and more difficult items are needed to bridge content gaps for all 9 domains to match the ability levels of student pharmacists.
• Campbell, A. M., Antwi, P. B., Davis, L. E., & Warholak, T. L. (2025).

  Fixed, Systematically Formed versus Continuously Changing Random Team Assignments and Outcomes in a Therapeutics Course

  . American Journal of Pharmaceutical Education, 89(Issue 3). doi:10.1016/j.ajpe.2025.101370
  More info

  Objective: This study examined the association between fixed and randomly changing teams on workshop preparation and learning outcomes. Methods: In this crossover study, third-year therapeutics course students were randomized to complete workshops 1 to 4 in either fixed, systematically developed teams or teams randomly assigned before each session. They then crossed over for workshops 5 to 8. Students provided information on their grade point average, work experience, and leadership tendencies and completed an abbreviated version of the Motivated Strategies for Learning Questionnaire. After each workshop, students completed a quiz, reported the time spent preparing, and rated their perceived preparedness of themselves and their peers using a Likert scale from 1 (not at all prepared) to 5 (very well prepared). At the end of the semester, students reported their team formation preferences. Parametric data were compared using paired t tests, while nonparametric data were analyzed using Wilcoxon signed-rank tests. Results: Of the 66 students who participated in the study, 49 (74.2%) preferred working in fixed teams over random teams, and 44 (66.7%) perceived fixed teams as the most effective for their learning. There was no significant difference in mean postworkshop quiz scores (78.7% fixed vs 77.4% random), mean exam scores (77.9% vs 77.6%), or median time spent preparing for a workshop (91.3 vs 95.6 min). Students perceived themselves as more prepared when working in fixed teams, but there was no difference in their perception of peer preparedness. Conclusion: Although students preferred and felt more prepared in fixed teams, there was no difference in learning outcomes or preparation time between the 2 team formation methods.
• Noureldin, M., Coe, A. B., DeLellis, T., Clifford, K. M., Freire-Cobo, C., Reilly, M., Campbell, A. M., Nagy, M. W., Adeoye-Olatunde, O. A., Sharma, M., & Sadowski, C. A. (2025).

  The state of the academic pharmacy workforce specializing in geriatrics

  . Gerontology and Geriatrics Education, 46(Issue). doi:10.1080/02701960.2025.2466199
  More info

  Objective: To describe the training, career experiences, and roles and responsibilities of faculty members in American and Canadian schools/colleges of pharmacy involved in geriatrics-focused teaching, research, practice, or service. Methods: A cross-sectional, web-based, self-administered survey was developed and pre-tested. Pharmacy faculty members with experience and/or expertise in geriatrics-focused practices or scholarships and/or who taught geriatrics-focused topics in US or Canadian pharmacy programs were eligible for participation. Participants were recruited using a multi-pronged approach between June and November 2022. Findings: A total of 131 completed and non-duplicate surveys were received. Ninety percent of respondents were from US programs and 64.9% worked in public institutions. Sixty-two percent reported greater than 40% teaching efforts, and 39% indicated they were the only person in their program to advocate for geriatrics-focused content. Most reported expectations for scholarship (96.2%), and 77.1% maintained a clinical practice. Among those with research expectations, 53.5% agreed they had an adequate percentage allocation dedicated to research. Conclusion: Geriatrics pharmacy faculty report geriatrics and non-geriatrics teaching expectations, clinical practice workloads, and less time for scholarly productivity. Most respondents have extensive experience in geriatrics; however, many perceive themselves to be the only advocates for geriatrics-focused topics in their programs.
• Campbell, A. M., Pae, E., Lee, E., Jacisin, T., Price, A., & DeAngelo, J. (2024). Off-Label Reduced Dose Apixaban in Older Adults With Atrial Fibrillation and Associated Outcomes. Annals of Pharmacotherapy, 58(Issue 6). doi:10.1177/10600280231199137
  More info

  Background: Apixaban is commonly used to prevent stroke in older adults with nonvalvular atrial fibrillation (AF). Although its package insert has specific dose reduction criteria, providers may dose reduce outside of these parameters based on clinical scenarios. Objective: The primary objective was to determine the incidence of apixaban off-label reduced dosing, while secondarily determining the safety and efficacy outcomes associated with such dosing. Methods: A retrospective analysis of patients aged 65 and older with orders for apixaban for AF was institutional review board (IRB)-approved and conducted across 3 academic medical centers. Patients receiving off-label reduced-dose apixaban (ie, “underdosed”) were matched to a cohort of patients dosed according to the package insert at the standard dosing (5 mg twice daily) using stratified random sampling. Secondary outcomes included 1-year incidence of major bleeding, clinically relevant non-major bleeding (CRNMB), stroke or transient ischemic attack (TIA), and mortality. The Fisher exact tests were used to compare between-group differences. Results: Of the 1172 patients meeting initial inclusion criteria, 201 (17%) were dosed off-label, with 175 (15%) “underdosed.” The 147 “underdosed” patients with documented follow-up were matched with 139 patients receiving standard Food and Drug Administration (FDA)-labeled dosing. There were no significant differences in incidence of stroke (2.7% vs 2.2%), major bleeding (0% vs 0.7%), and CRNMB (2.7% vs 1.4%) in the off-label reduced dosing versus standard dosing groups. All-cause mortality was higher in the off-label reduced-dose group (16 [10.9%] vs 2 [1.4%], P < 0.05). Conclusion and Relevance: Older adults with nonvalvular AF are commonly prescribed lower-than-recommended doses of apixaban. However, no significant association was found between empiric off-label reduced dosing and stroke or bleeding outcomes.
• Weygint, A., Whittington, B., Lee, J. K., & Campbell, A. M. (2024). Effect of a Virtual Game, 'Name That Band,' on Older People's and PharmD Students' Feelings of Social Isolation During COVID-19. The Senior Care Pharmacist, 39(1), 22-29. doi:10.4140/TCP.n.2024.22
• Campbell, A. M., Pae, E., Lee, E., Jacisin, T., Price, A., & DeAngelo, J. (2023). Off-label reduced dose apixaban in older adults with atrial fibrillation and associated outcomes. Annals of Pharmacotherapy. doi:10.1177/10600280231199137
• Marupuru, S., Arku, D., Campbell, A. M., Slack, M. K., & Lee, J. K. (2022). Melatonin and/or ramelteon for the treatment of insomnia in older adults: A systematic review and meta-analysis. Journal of Clinical Medicine, 11(17), 5138.
• Chen, Q., An, L., Lu, Y., Campbell, A. M., & Khan, S. A. (2021). N-Acetylcysteine for Cardiac Protection during Coronary Artery Reperfusion: A Comprehensive Systematic Review and Meta-Analysis of Twenty Eight Randomized Controlled Trials. Frontiers Cardiovascular Medicine, 8(752939). doi:doi: 10.3389/fcvm.2021.752939
• Khan, S. A., Campbell, A. M., Lu, Y., An, L., & Chen, Q. (2020). N-Acetylcysteine for Cardiac Protection during Coronary Artery Reperfusion: A Comprehensive Systematic Review and Meta-Analysis of Twenty Eight Randomized Controlled Trials. Oxidative Medicine and Cell Longevity.
• Khan, S. A., Campbell, A. M., Lu, Y., An, L., Alpert, J. S., & Chen, Q. M. (2021). N-Acetylcysteine for Cardiac Protection During Coronary Artery Reperfusion: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Frontiers in cardiovascular medicine, 8, 752939.
  More info

  Coronary artery reperfusion is essential for the management of symptoms in the patients with myocardial ischemia. However, the benefit of reperfusion often comes at an expense of paradoxical injury, which contributes to the adverse events, and sometimes heart failure. Reperfusion is known to increase the production of reactive oxygen species (ROS). We address whether N-acetylcysteine (NAC) reduces the ROS and alleviates reperfusion injury by improving the clinical outcomes. A literature search for the randomized controlled trials (RCTs) was carried out in the five biomedical databases for testing the effects of NAC in patients undergoing coronary artery reperfusion by percutaneous coronary intervention, thrombolysis, or coronary artery bypass graft. Of 787 publications reviewed, 28 RCTs were identified, with a summary of 2,174 patients. A meta-analysis using the random effects model indicated that NAC administration during or prior to the reperfusion procedures resulted in a trend toward a reduction in the level of serum cardiac troponin (cTn) [95% , standardized mean difference (SMD) -0.80 (-1.75; 0.15), = 0.088, = 262 for control, 277 for NAC group], and in the incidence of postoperative atrial fibrillation [95% , relative risk (RR) 0.57 (0.30; 1.06), = 0.071, = 484 for control, 490 for NAC group]. The left ventricular ejection fraction or the measures of length of stay in intensive care unit (ICU) or in hospital displayed a positive trend that was not statistically significant. Among the nine trials that measured ROS, seven showed a correlation between the reduction of lipid peroxidation and improved clinical outcomes. These lines of evidence support the potential benefit of NAC as an adjuvant therapy for cardiac protection against reperfusion injury.
• McQuade, B. M., & Campbell, A. (2021). Drug Prescribing: Drug-Drug Interactions. FP essentials, 508(Issue).
  More info

  Drug-drug interactions (DDIs) occur when one drug adds to or diminishes the effect of another drug (ie, pharmacodynamic interaction) or affects the absorption, distribution, metabolism, or excretion of another drug (ie, pharmacokinetic interaction). Such interactions cause 26% of all adverse drug events (ADEs) and are associated with a significant burden on the health care system through increased hospitalizations. Some of the most common DDIs result from alterations in drug metabolism through interactions with cytochrome P450 enzymes and absorption through interactions with P-glycoproteins. Other common DDIs occur because of additive effects, including combinations of drugs that increase the risk of seizures, prolong the QT interval, increase central nervous system depression, and increase the risk of serotonin syndrome. Drug-related clinical decision support has been shown to improve the quality of patient care and decrease ADE rates. However, alerts generated by such systems should be interpreted using clinical judgment to determine the risks and benefits of certain drugs on a patient-specific basis. Family physicians can prevent clinically significant DDIs and optimize drug safety by using drug interaction software, along with a general understanding of common DDI mechanisms and collaboration with pharmacists.
• McQuade, B. M., & Campbell, A. (2021). Drug Prescribing: Drug-Drug Interactions. FP essentials, 508, 25-32.
  More info

  Drug-drug interactions (DDIs) occur when one drug adds to or diminishes the effect of another drug (ie, pharmacodynamic interaction) or affects the absorption, distribution, metabolism, or excretion of another drug (ie, pharmacokinetic interaction). Such interactions cause 26% of all adverse drug events (ADEs) and are associated with a significant burden on the health care system through increased hospitalizations. Some of the most common DDIs result from alterations in drug metabolism through interactions with cytochrome P450 enzymes and absorption through interactions with P-glycoproteins. Other common DDIs occur because of additive effects, including combinations of drugs that increase the risk of seizures, prolong the QT interval, increase central nervous system depression, and increase the risk of serotonin syndrome. Drug-related clinical decision support has been shown to improve the quality of patient care and decrease ADE rates. However, alerts generated by such systems should be interpreted using clinical judgment to determine the risks and benefits of certain drugs on a patient-specific basis. Family physicians can prevent clinically significant DDIs and optimize drug safety by using drug interaction software, along with a general understanding of common DDI mechanisms and collaboration with pharmacists.
• McQuade, B. M., & Campbell, A. (2021). Drug Prescribing: Polypharmacy and Deprescribing. FP essentials, 508, 33-40.
  More info

  Polypharmacy, defined as concurrent use of five or more drugs, can occur in patients of all ages. Polypharmacy may be appropriate or inappropriate. Appropriate polypharmacy is defined as "use of the correct drugs under appropriate conditions [in order] to treat the right diseases." A prescribed drug becomes inappropriate when its benefits no longer outweigh its risks. Inappropriate polypharmacy has been shown to increase the risks of hospitalization, adverse drug events, clinically relevant drug interactions, and all-cause mortality. Many tools are available to aid physicians in identifying inappropriate polypharmacy. Implicit tools, such as the Medication Appropriateness Index (MAI), provide guidance to be used alongside clinical judgement. Explicit tools, such as the American Geriatrics Society (AGS) Beers Criteria, provide lists of potentially inappropriate drugs and recommend alternatives. Collaboration with pharmacists is important in assessing drug appropriateness. It has been shown to reduce drug-related problems, emergency department visits, and hospitalizations and to improve overall patient health. A patient-centered, team-based approach is recommended in the process of deprescribing inappropriate drugs. Deprescribing should be approached in the same stepwise manner as prescribing of new drugs, and should include patient agreement to changes, evidence-based rationales, and use of dosage tapering strategies.
• McQuade, B. M., Campbell, A. M., Yuet, W. C., & Lounsbery, J. L. (2020). Pharmacotherapy and Prescribing Update. FP Essentials.
• Xie, C., Vraney, J., Oman, N., Erstad, B. L., & Campbell, A. M. (2021). Initiation of Oseltamivir in Critically Ill Patients: Variations in Prescribing Practices.. The Annals of pharmacotherapy, 55(2), 265-266. doi:10.1177/1060028020942513
• Campbell, A. M., Martin, J. R., & Erstad, B. L. (2020). Corticosteroid Tapering Regimens in Rheumatic Disease: A Systematic Review. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 26(2), 41-47.
• Campbell, A. M., Vraney, J., Oman, N., Xie, C., & Erstad, B. L. (2020). Initiation of Oseltamivir in Critically Ill Patients: Variations in Prescribing Practices. The Annals of pharmacotherapy, 1060028020942513.
• Hirokawa, R., Campbell, A. M., Das, N., Haugh, A., & Wilson, S. A. (2020). In premenopausal women with bleeding caused by fibroids, do oral contraceptive pills reduce menorrhagia?. Evidence-Based Practice, 23(Issue 8). doi:10.1097/ebp.0000000000000412
• Hirokawa, R., Campbell, A. M., Das, N., Haugh, A., & Wilson, S. A. (2020). In premenopausal women with bleeding due to fibroids, do oral contraceptive pills reduce menorrhagia?. Evidence-Based Practice. doi:10.1097/EBP.0000000000000412
• Perales, I. J., San Agustin, K., DeAngelo, J., & Campbell, A. M. (2020). Rivaroxaban Versus Warfarin for Stroke Prevention and Venous Thromboembolism Treatment in Extreme Obesity and High Body Weight. Annals of Pharmacotherapy, 54(Issue 4). doi:10.1177/1060028019886092
  More info

  Background: Limited clinical data exist describing the use of direct-acting oral anticoagulants (DOACs) in patients with body mass index (BMI) >40 kg/m2 or body weight >120 kg. Thus, DOAC therapy in this population remains controversial. Objectives: To investigate rivaroxaban as a safe and effective alternative to warfarin for venous thromboembolism (VTE) treatment and prevention of stroke in patients with atrial fibrillation identified as extremely obese or of high body weight. Methods: A retrospective chart review was performed at 2 academic medical centers in patients ≥18 years old and BMI >40 kg/m2 or weight >120 kg, newly initiated on warfarin or rivaroxaban for atrial fibrillation or VTE treatment. The primary end point was incidence of clinical failure, defined as VTE recurrence, stroke incidence, and mortality, within 12 months of initiation. Secondary end points included length of stay (LOS) and bleeding complications. Results: A total of 176 patients were included, with 84 and 92 patients in the rivaroxaban and warfarin arms, respectively. Clinical failure was lower in the rivaroxaban group but did not reach statistical significance when compared with warfarin (5% vs 13%; P = 0.06). LOS was significantly shorter in the rivaroxaban arm (2 days [1-3] vs 4 days [2-7], P < 0.0001). Percentage of bleeding complications was higher in the rivaroxaban arm but not statistically significant (8% vs 2%, P = 0.06). Conclusion and Relevance: Although not statistically significant, rivaroxaban trended toward a lower incidence of clinical failure while demonstrating a significantly shorter LOS when compared with warfarin for VTE treatment or atrial fibrillation in morbidly obese or high-body-weight patients.
• Perales, I. J., San Agustin, K., DeAngelo, J., & Campbell, A. M. (2020). Rivaroxaban Versus Warfarin for Stroke Prevention and Venous Thromboembolism Treatment in Extreme Obesity and High Body Weight. The Annals of pharmacotherapy, 54(4), 344-350.
• Campbell, A. M., Axon, D. R., Martin, J. R., Slack, M. K., Mollon, L., & Lee, J. K. (2019). Melatonin for the prevention of postoperative delirium in older adults: A systematic review and meta-analysis. BMC Geriatrics, 19(Issue 1). doi:10.1186/s12877-019-1297-6
  More info

  Background: Older surgical patients are at high risk of developing postoperative delirium. Non-pharmacological strategies are recommended for delirium prevention, but no pharmacological agents have compelling evidence to decrease the incidence of delirium. The purpose of this study was to assess whether perioperative melatonin decreases the incidence of delirium in older adults undergoing surgical procedures. Methods: A systematic search using PubMed/Medline, Embase, PsycINFO, CINAHL, and references of identified articles published in English between January 1990 and October 2017 was performed. Two independent reviewers screened titles and abstracts, and then extracted data following a full-text review of included articles with consensus generation and bias assessment. Studies reporting outcomes for melatonin or ramelteon use to prevent delirium in postoperative hospitalized patients (mean age ≥ 50 years) were eligible for inclusion. Data were pooled using a fixed-effects model to generate a forest plot and obtain a summary odds ratio for the outcome of interest (delirium incidence). Cochran's Q and I2 values were used to investigate heterogeneity. Results: Of 335 records screened, 6 studies were selected for the qualitative analysis and 6 were included in the meta-analysis (n = 1155). The mean age of patients in included studies ranged from 59 to 84 years. Patients in intervention groups typically received melatonin or ramelteon at daily doses of two to eight milligrams around cardiothoracic, orthopedic, or hepatic surgeries for one to nine days, starting on the evening before or the day of surgery. The incidence of delirium ranged from 0 to 30% in the intervention groups versus 4-33% in the comparator groups, and was significantly reduced in the melatonin group, with a summary effect of the meta-analysis yielding an odds ratio of 0.63 (95% CI 0.46 to 0.87; 0.006; I2 = 72.1%). A one study removed analysis reduced overall odds ratio to 0.310 (95% CI 0.19 to 0.50), while reducing heterogeneity (Cochran's Q = 0.798, I2 = 0.000). Conclusion: Perioperative melatonin reduced the incidence of delirium in older adults in the included studies. While optimal dosing remains an unanswered question, the potential benefit of melatonin and melatonin receptor agonists may make them a reasonable option to use for delirium prevention in older adults undergoing surgical procedures.
• Campbell, A. M., Axon, D. R., Mollon, L. E., Martin, J. R., Slack, M. K., & Lee, J. K. (2019). Melatonin for the prevention of postoperative delirium in older adults: A Systematic Review and Meta-analysis. BMC Geriatrics, 19(1), 272. doi:10.1186/s12877-019-1297-6
• Campbell, A. M., Axon, D. R., Mollon, L. E., Martin, J. R., Slack, M. K., & Lee, J. K. (2019). Melatonin for the prevention of postoperative delirium in older adults: A Systematic Review and Meta-analysis. BMC Geriatrics.
• Campbell, A. M., Martin, J. R., & Erstad, B. L. (2019). Tapering Regimens Following Medium to High Dose Extended Duration Corticosteroid Monotherapy in Adults with Rheumatic Disease: A Systematic Review. Journal of Clinical Rheumatology.
• Campbell, A. M., Vraney, J., Oman, N., Xie, C., & Erstad, B. L. (2019). Oseltamivir prescribing practices for influenza and associated outcomes in the critically ill patient. Journal of the Intensive Care Society.
• Erstad, B. L., Martin, J. R., & Campbell, A. M. (2018). Tapering Regimens Following Medium to High Dose Extended Duration Corticosteroid Monotherapy in Adults with Rheumatic Disease: A Systematic Review. Journal of Clinical Rheumatology. doi:https://doi.org/10.1097/RHU.0000000000000917
• Lee, J. K., Lee, J. K., Slack, M. K., Slack, M. K., Martin, J. R., Martin, J. R., Mollon, L. E., Mollon, L. E., Axon, D. R., Axon, D. R., Campbell, A. M., & Campbell, A. M. (2019). Melatonin for the prevention of postoperative delirium in older adults: A Systematic Review and Meta-analysis. BMC Geriatrics.
• Perales, I. J., San Agustin, K., DeAngelo, J., & Campbell, A. M. (2019). Rivaroxaban versus warfarin for stroke prevention and venous thromboembolism treatment in extreme obesity and high body weight. Annals of Pharmacotherapy, [e-pub ahead of print].
• Pogge, E., Sibicky, S., & Campbell, A. (2019). Evaluating Prescribing Practices of Apixaban in the Elderly. The Senior care pharmacist, 34(Issue 8).
  More info

  OBJECTIVE: The aim of this study was to evaluate prescribing practices for elderly patients started on apixaban in multiple practice settings. DESIGN: Retrospective, chart review. SETTING: One outpatient and three inpatient settings in Arizona and Massachusetts. PATIENT, PARTICIPANTS: Patients who received a new order for apixaban between July 1, 2015, and December 31, 2016. Inclusion criteria included adults 65 years of age and older who were receiving apixaban for atrial fibrillation or venous thromboembolism (VTE) at a current treatment dose. There were 1,045 patients included, the average age was 78 years, 52% were male, and 90% had atrial fibrillation. MAIN OUTCOME MEASURE: Appropriate prescribing of apixaban based on Food and Drug Administration (FDA)-labeling (age, weight, serum creatinine). RESULTS: Six patients who were on hemodialysis were excluded from the analysis, leaving 1,039 patients to be analyzed. 16.2% (168/1,039) of patients had an incorrect dose of apixaban prescribed based on their indication. Of those, 75% (126/168) were taking the medication for atrial fibrillation and 25% (42/168) for VTE. For those with atrial fibrillation (n = 126), the majority of inappropriate orders resulted from doses that were lower than indicated (113/126). CONCLUSION: This research suggests that elderly patients may receive inappropriately lower doses of apixaban than indicated, which may decrease the effectiveness of the medication. This research supports the fact that pharmacists can play a vital role in anticoagulation stewardship by verifying apixaban doses for accuracy.
• Pogge, E., Sibicky, S., & Campbell, A. M. (2018). Evaluating Prescribing Practices of Apixaban in the Elderly. The Consultant Pharmacist.
  More info

  Working with faculty at other colleges of pharmacy across the country to examine prescribing practices of the direct oral anticoagulants in older adults in both the inpatient and outpatient settings. Will combine all of our data and write about conducting research with students in collaboration with other pharmacy schools.
• Pogge, E., Sibicky, S., & Campbell, A. M. (2019). Evaluating Prescribing Practices of Apixaban in the Elderly. Senior Care Pharmacist, 34(8), 514-519.
  More info

  Worked with faculty at other colleges of pharmacy across the country to examine prescribing practices of the direct oral anticoagulants in older adults in both the inpatient and outpatient settings.
• Campbell, A. M., Coley, K. C., Corbo, J. M., Delellis, T. M., Joseph, M., Thorpe, C. T., McGivney, M. S., Klatt, P., Cox-Vance, L., Balestrino, V., & Sakely, H. (2018). Pharmacist-led drug therapy problem management in an interprofessional geriatric care continuum: A subset of the PIVOTS group. American Health and Drug Benefits, 11(Issue 9).
  More info

  BACKGROUND: Drug therapy problems, which are adverse events involving medications that can ultimately interfere with a patient’s therapeutic goals, occur frequently in older adults. If not identified, resolved, and prevented through clinical decision-making, drug therapy problems may negatively affect patient health outcomes. OBJECTIVE: To quantify the impact of pharmacist interventions on the care of older adults by identifying the most common drug therapy problems, the medications most often involved in these problems, and the actions taken by pharmacists to resolve these problems. METHODS: This retrospective chart review included individuals seen by a geriatric pharmacist in one geriatric practice, where 4 pharmacists provide continuous, comprehensive medication management across 2 outpatient geriatric clinics, skilled-nursing facilities, and assisted-living facilities. The individuals were seen between August 2014 and November 2015. For all patient care encounters during this time frame, pharmacists used the Assurance System to document each drug therapy problem, the medications involved, the patient’s care setting (ie, outpatient clinic, assisted-living facility, skilled-nursing facility), the actions taken to resolve any drug therapy problems, and the estimated 90-day impact on the patient and the healthcare system. RESULTS: A total of 3100 drug therapy problems were identified during 3309 patient–pharmacist encounters for 452 patients (mean age, 81.4 years), 48.7% of whom were seen in the skilled-nursing facility. The most common drug therapy problem was dose too low, followed by dose too high, and warfarin was the most common drug associated with drug therapy problems. Pharmacists provided 4921 interventions, often more than 1 intervention per drug therapy problem, for 275 different medications. Laboratory monitoring and dose change were the most common interventions, with an estimated annual financial savings between $268,690 and $270,591. CONCLUSION: Older patients are a vulnerable patient population who often receive unsafe medication regimens, which can result in adverse drug reactions and other critical problems. When integrated into interprofessional geriatric care teams, pharmacists’ interventions provide an invaluable qualitative and monetary resource to the medication-based management of patients with well-recognized, high-risk geriatric syndromes as they transition to and through various levels of care.
• Campbell, A. M., Coley, K., Corbo, J., DeLellis, T., Joseph, M., Thorpe, C., McGivney, M. S., Klatt, P., Cox-Vance, L., Balestrino, V., & Sakely, H. (2018). Pharmacist-led Drug Therapy Problem Management in an Interprofessional Geriatric Care Continuum: A Subset of the PIVOTS Group. American Health & Drug Benefits, 11(9), 469-477.
• Campbell, A. M., Martin, J. R., & Erstad, B. L. (2018). Corticosteroid Tapering Regimens in Rheumatic Disease: A Systematic Review.. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases. doi:10.1097/rhu.0000000000000917
  More info

  Corticosteroids have long been used to effectively treat rheumatic disorders, but adverse effects associated with extended-duration regimens generate disagreement among clinicians regarding optimal tapering strategies. The objective of this systematic review was to assess clinical outcomes of differing tapering regimens after corticosteroid monotherapy in adults with rheumatic disorders..A systematic review of Medline/PubMed, Embase, Cochrane, International Pharmaceutical Abstracts, Web of Science, Scopus, Global Index Medicus, American College of Rheumatology, gray literature, and reference lists up to June 27, 2018, was conducted by 2 authors. Randomized controlled trials, case-control studies, and prospective observational studies comparing at least 2 tapering strategies of medium- to high-dose (>7.5 mg but ≤100 mg oral prednisone equivalent daily), extended-duration (≥10 days) corticosteroids were included if they reported at least 1 efficacy and 1 adverse effect parameter..Two studies met criteria for the review, which included 62 patients. One study examined a prednisolone versus a modified release prednisone taper for giant cell arteritis and suggested 80% (n = 4) and 85.7% (n = 6) remission rates, respectively, at 26 weeks. The other study examined a methylprednisolone versus a prednisone taper for polymyalgia rheumatica and reported 100% and 89% remission rates, respectively, at 26 weeks. Adverse effects reported between the 2 studies included sleep, hyperglycemia, infection, and fractures. However, the studies were not powered to detect differences in these outcomes..There is no high-level evidence to guide tapering until discontinuation after extended courses of medium- to high-dose treatment regimens, as current guidelines rely heavily on expert opinion and small case series with a trial-and-error approach. This review supports the need for additional research to shift tapering recommendations to a more evidence-based practice.
• Campbell, A. M., Martin, J. R., & Erstad, B. L. (2018). Tapering Regimens Following Medium to High Dose Extended Duration Corticosteroid Monotherapy in Adults with Rheumatic Disease: A Systematic Review. Journal of Clinical Rheumatology. doi:https://doi.org/10.1097/RHU.0000000000000917
• Chaudhri, P., Campbell, A. M., & Wilson, S. A. (2016). Does coffee consumption lead to poor outcomes in patients with tachycardia?. Evidence-Based Practice, 19(9), 13-14.
• Chaudhri, P., Campbell, A. M., & Wilson, S. A. (2016). Does coffee consumption lead to poor outcomes in patients with tachycardia?. Evidence-Based Practice, 19(Issue 9).
• Campbell, A. (2015). The Benefits of Faculty Development Span Far Beyond Teaching Skills. American Journal of Pharmaceutical Education, 79(Issue 7). doi:10.5688/ajpe797108
• Campbell, A. (2015). The Benefits of Faculty Development Span Far Beyond Teaching Skills. American journal of pharmaceutical education, 79(7), 108.
• Persky, A. M., Henry, T., & Campbell, A. (2015). An exploratory analysis of personality, attitudes, and study skills on the learning curve within a team-based learning environment. American Journal of Pharmaceutical Education, 79(Issue 2). doi:10.5688/ajpe79220
  More info

  Objective. To examine factors that determine the interindividual variability of learning within a teambased learning environment. Methods. Students in a pharmacokinetics course were given 4 interim, low-stakes cumulative assessments throughout the semester and a cumulative final examination. Students’ Myers-Briggs personality type was assessed, as well as their study skills, motivations, and attitudes towards team-learning. A latent curve model (LCM) was applied and various covariates were assessed to improve the regression model. Results. A quadratic LCM was applied for the first 4 assessments to predict final examination performance. None of the covariates examined significantly impacted the regression model fit except metacognitive self-regulation, which explained some of the variability in the rate of learning. There were some correlations between personality type and attitudes towards team learning, with introverts having a lower opinion of team-learning than extroverts. Conclusion. The LCM could readily describe the learning curve. Extroverted and introverted personality types had the same learning performance even though preference for team-learning was lower in introverts. Other personality traits, study skills, or practice did not significantly contribute to the learning variability in this course.
• Persky, A. M., Henry, T., & Campbell, A. (2015). An exploratory analysis of personality, attitudes, and study skills on the learning curve within a team-based learning environment. American journal of pharmaceutical education, 79(2), 20.
  More info

  To examine factors that determine the interindividual variability of learning within a team-based learning environment.

Presentations

• Campbell, A. M. (2025).

  Pizza and Beers Criteria

  . American Society of Consultant Pharmacists (ASCP) 6th Annual Pizza and Beers Criteria Discussion.
• Campbell, A. M. (2025, June).

  American Association of Colleges of Pharmacy (AACP) Geriatric Pharmacy SIG Annual Business Meeting

  . AACP Annual Business Meetings. Virtual.
• Campbell, A. M. (2025, November).

  Sleep Health in Older Adults

  . Training Session for Interprofessional Geriatric Screening Clinic at St. Luke’s Assisted Living Home. Tucson, AZ.
• Campbell, A. M., & Mehrara, M. (2025, March).

  Medication Safety and Polypharmacy in Older Adults

  . Training Session for Interprofessional Geriatric Screening Clinic at St. Luke’s Assisted Living Home. Tucson, AZ.
• Campbell, A. M., & Mike, L. A. (2025, July 2025).

  Geriatric Pharmacy SIG Networking Session

  . AACP Annual Meeting. Chicago, IL.
• Breese, D., DeLellis, T., Mike, L. A., & Campbell, A. M. (2024, December). Cultivating a Sense of Belonging in the Academy by Breaking Down Generational Biases. American Association of Colleges of Pharmacy Webinar. Virtual.
• Breese, D., DeLellis, T., Mike, L. A., & Campbell, A. M. (2024, July). Cultivating a Sense of Belonging in the Academy by Breaking Down Generational Biases. American Association of Colleges of Pharmacy Annual Meeting. Boston, MA.
• Campbell, A. M. (2024, March). Sleep Health in Older Adults. Training Session for Interprofessional Geriatric Screening Clinic at St. Luke’s Assisted Living Home. Tucson, AZ.
• Cooper, J. B., & Campbell, A. M. (2024, July 2024). Geriatric Pharmacy SIG Networking Session. AACP Annual Meeting. Boston, MA.
• Watkins, J., Edwards, C. J., Parker, K., & Campbell, A. M. (2024). Incidence of acute kidney injury in hospitalized older adults receiving ketorolac. Southwestern States Pharmacy Residency Conference. Phoenix, AZ.
• Campbell, A. M. (2023). Opportunities in Geriatric Pharmacy: Residencies and Beyond. American Society of Consultant Pharmacists (ASCP) Student Chapter Meeting. University of Arizona R. Ken Coit College of Pharmacy.
• Campbell, A. M. (2023). Pizza and Beers Criteria. American Society of Consultant Pharmacists (ASCP) 4th Annual Pizza and Beers Criteria Discussion.
• Campbell, A. M. (2023). Top Tips from Your Pharmacy Allies to Promote Medication Safety. University of Arizona College of Medicine Residency Bootcamp. University of Arizona College of Medicine.
• Campbell, A. M. (2023, April). Medication Safety in Older Adults (& the Beers Criteria). Interprofessional Geriatric Screening Clinic at St. Luke’s Assisted Living Home. Tucson, AZ.
• Campbell, A. M. (2023, Fall). Medications and Fall Risk in Older Adults. Falls Prevention Fair 2023. University of Arizona Health Sciences Innovations Building: Banner – University Medicine, University of Arizona Health Sciences, and the Division of Trauma, Surgical Critical Care, Burns and Acute Care Surgery.
• Campbell, A. M. (2023, Fall). When Less is More: Deprescribing in Older Adults. PharmTalk: An R. Ken Coit College of Pharmacy Community Lecture Series. University of Arizona Health Sciences Innovations Building.
• Campbell, A. M. (2023, November). OTC and Herbal Dietary Supplement Safety in Older Adults. Interprofessional Geriatric Screening Clinic at St. Luke’s Assisted Living Home. Tucson, AZ.
• Campbell, A. M., DeLellis, T., Williams, B., & Nagy, M. (2023, February). Teaching to, for, and with multiple generations. AACP Webinar SeriesAACP Geriatrics SIG.
• Cullen, T., Fain, M., Anderson, A., & Campbell, A. M. (2023, February). Town Hall on Senior Health. Pima County Department of Health and Banner University Medicine Town Hall on Senior Health. Virtual: Pima County Department of Health and Banner University Medicine.
• Schrunk, M., Birch Yeoman, T. C., DeAngelo, J., Konecnik, M., & Campbell, A. M. (2023, June). Apixaban induction dose duration and associated outcomes following parenteral anticoagulation in the management of venous thromboembolism. Southwestern States Pharmacy Residency Conference. Phoenix, AZ.
• Birch Yeoman, T. C., Kummer, K., DeAngelo, J., & Campbell, A. M. (2022). Rivaroxaban induction dose duration and associated outcomes following parenteral anticoagulation in the management of venous thromboembolism. Southwestern States Residency Conference. Phoenix, AZ.
  More info

  Presented by PGY1 pharmacy resident Claire Birch Yeoman
• Campbell, A. M. (2022). Opportunities in Geriatric Pharmacy: Residencies and Beyond. American Society of Consultant Pharmacists (ASCP) Student Chapter Meeting. University of Arizona R. Ken Coit College of Pharmacy.
• Campbell, A. M. (2022). Pizza and Beers Criteria. American Society of Consultant Pharmacists (ASCP) 3rd Annual Pizza and Beers Criteria Discussion.
• Campbell, A. M. (2022). Top Tips from Your Pharmacy Allies to Promote Medication Safety. University of Arizona College of Medicine Residency Bootcamp. University of Arizona College of Medicine.
• Campbell, A. M. (2022, Fall 2022). Medications and Fall Risk in Older Adults. Banner Fall Prevention Fair. University of Arizona Health Sciences Innovations Building: Banner University Medicine and the University of Arizona Health Sciences.
• Campbell, A. M., DeLellis, T., Williams, B., & Nagy, M. (2022, Summer). Teaching to, for, and with multiple generations. AACP Pharmacy Education 2022. Grapevine, TX: AACP Geriatrics SIG.
• Campbell, A. M., Denny, L. A., & Gasser, S. (2022). Introduction to Interprofessionalism Panel. Introduction to Interprofessionalism Event. University of Arizona Health Sciences: Center for Transformative Interprofessional Healthcare (CTIPH).
• Kummer, K., Birch Yeoman, T. C., DeAngelo, J., & Campbell, A. M. (2022). Rivaroxaban induction dose duration and associated outcomes following parenteral anticoagulation in the management of venous thromboembolism. Western States Residency Conference. San Diego, CA.
  More info

  Presented by PGY2 internal medicine pharmacy resident Katie Kummer
• Pae, E., Lee, E., DeAngelo, J., Price, A., & Campbell, A. M. (2021, Summer). Outcomes Associated With Inappropriately Dosed Apixaban in Older Adult Patients With Atrial Fibrillation. Southwestern States Residency Conference. Phoenix, AZ.
• Campbell, A. M. (2020, March). A Practical Guide to Geriatric Medicine & Safe Medication Use in Older Adults. University of Arizona / Banner - UMC Tucson Internal Medicine Residency Academic Half-Day. Banner - University Medical Center Tucson.
• Hogan, L., Campbell, A. M., Skef, S., & Williams, A. (2020, Spring 2020). Writing Letters to the Editor: A Gateway to Scholarly Publication for Medical Students and Educators. 2020 STFM Conference on Medical Student Education. Portland, OR.
• Jacisin, T., DeAngelo, J., Price, A., & Campbell, A. M. (2020, May). Evaluation of Apixaban in Older Adult Patients with Atrial Fibrillation. Western States Conference. Virtual (San Diego, CA).
• Meador, S. L., Campbell, A. M., & Whitfield, M. (2020, May). Thromboprophylaxis in Older Adults Following Hip Fracture Surgery. Western States Conference. Virtual (San Diego).
• Campbell, A. M. (2018, Fall 2019). Pharmacotherapy Update. American Geriatrics Society Annual Scientific Meeting. Portland, OR.
• Campbell, A. M. (2019, Fall 2019). Medications and Fall Risk in Older Adults. Banner Fall Prevention Fair. University of Arizona Health Sciences Innovations Building: Banner University Medicine and the University of Arizona Health Sciences.
• Campbell, A. M., & Jernberg, J. (2019, Summer 2019). Top 3 Pharmacologic Considerations in Geriatric Trauma Patients. BUMCT Trauma Academic Hour. Banner - University Medical Center Tucson.
• Campbell, A. M., Hutchison, L., & Elliott, D. (2019, Spring). Pharmacotherapy Update: 2019. American Geriatrics Society Annual Scientific Meeting. Portland, OR.
  More info

  Newly Approved Medications and Place in Therapy for Older Adults
• Campbell, A. M., & Sanguineti, V. A. (2018, August). Geriatrics in Orthopaedics. Orthopaedic Surgery Grand Rounds. Kiewit Auditorium, Banner - University Medical Center Tucson: University of Arizona Department of Orthopaedic Surgery.
• Campbell, A. M., & Sanguineti, V. A. (2018, March). Getting Creative with Pain Management: When Plan A Doesn't Work (or Isn't Available). Internal Medicine Hospitalist Meeting. Banner - University Medical Center Tucson.
• Campbell, A. M., Wild, J., & Joseph, B. (2018, September). Stand Tall Senior Falls Program: Medications and the Risk of Falls. Banner - University Medical Center Tucson Falls Prevention Month Event. Kiewit Auditorium, Banner - University Medical Center Tucson.
• Frazier, W. T., Campbell, A. M., Ayers, G., Chaudhri, P., Niedermier, V., Turco, N., & Wilson, S. A. (2018, May). Learner Engagement Consult: Call IT - Interactive Teaching Methods in Family Medicine. Society of Teachers of Family Medicine Annual Spring Conference. Washington, DC.
  More info

  Interactive teaching is a two-way process of active participant engagement with the learner(s), the educator, and the content. Learning by interactive engagement occurs through discussion, collaboration, and critical thinking. This workshop is designed for family medicine educators to learn and practice how to actively engage learners using five interactive teaching methods that can be easily incorporated into any teaching environment: precepting, small group teaching, or large didactics. Participants will be placed into five small groups that rotate through five stations that each focus on a different interactive teaching method: 1) think-pair-share, 2) quick think, 3) mini-cases, 4) minute writes, and 5) jigsaw learning. Participants will learn how to incorporate these interactive methods into their teaching. In each group, faculty development-trained facilitators will describe the teaching method and participants will practice the technique. Using a small group format, participants will be also be able to ask questions and share their own experiences using interactive teaching in their practice. Practicing these methods and sharing perspectives with fellow participants are both vital components of this workshop.On completion of this session active participants will be able to:1) Describe five interactive teaching methods2) Apply interactive teaching methods to family medicine learners3) Modify interactive teaching methods to Generation Y/Millennial learners
• Campbell, A. M. (2017, October). Medication Management. Aging Mastery Program®. Green Valley, AZ: Pima Council on Aging.
• Campbell, A. M. (2017, October). Polypharmacy and Medication Safety. Interprofessional Geriatric Screening Clinic at St. Luke’s Assisted Living Home. Tucson, AZ.
• Frazier, W., Campbell, A. M., Wilson, S. A., Chaudhri, P., Niedermier, V., Turco, N., & Springer, S. (2017, May). Learning Out Loud (LOL): Interactive Family Medicine Teaching that Engages Learners. Society of Teachers of Family Medicine Annual Spring Conference. San Diego, California.
• Campbell, A. M., DeLellis, T., Hirokawa, R., Felton, M., & Leman, K. (2016, May). Using BIG WORDS to Understand Big Words: Innovative Strategies in Geriatric Patient Education. Society of Teachers of Family Medicine Annual Spring Conference. Minneapolis, Minnesota.
  More info

  In today’s fast-paced health care environment, family medicine residents and faculty often struggle with effective delivery of patient education, particularly in special populations such as older adults. In this session, participants will not only discuss best practices to maximize time when communicating with older adults, but they will also learn about and have the opportunity to practice three innovative strategies that can be incorporated into visits to enhance patient education in the geriatric population.Upon completion of this session, participants should be able to:Discuss geriatric-specific techniques for successful communication with older adults.List innovative methods that can be used when educating older adults.Integrate geriatric-specific patient education methods into your practice.
• Chaudhri, P., Campbell, A. M., Frazier, W., Trietley, G., & Giruzzi, N. (2016, May). CPR: Resuscitate Your Presentation. Society of Teachers of Family Medicine Annual Spring Conference. Minneapolis, Minnesota.
  More info

  Some of today’s learners are as old as PowerPoint. They have grown up in an era of technology. These tech-savvy learners expect quick, stimulating, and interactive learning, wary of lengthy, didactic, hour-long presentations. Constant advances in technology, although exciting, pose challenges for educators to continually update their modes of instruction. This session aims to provide both seasoned educators and new faculty with simple and quick steps to updating their presentations by incorporating technological tools to meet the needs of current learners.Upon completion of this session, participants should be able to:Examine ways in which technology can be used to update presentations and engage learners.Incorporate three applicable technologies into medical education presentations.Design tech-savvy presentations that engage learners using at least one new technological tool learned in the session.
• Chawla, A., Campbell, A. M., Bondar, A., & Larson, P. (2016, May). Faculty Development for Global Health Fellowship. Society of Teachers of Family Medicine Annual Spring Conference. Minneapolis, Minnesota.
  More info

  The World Health Organization recognizes family medicine as the foundation of global health care reform, specifically in resource poor countries. One approach to sustainable health care is the development of local educational programs. To avoid “brain drain,” these programs decrease the need for international travel for medical education. They often rely on faculty from first world countries to help and support their curricula until local faculty can be trained and recruited. While there are a number of postgraduate training programs to create global health primary care clinicians, only one program, Brown University, has a faculty development component. To meet the increasing demand for primary care educators, UPMC St. Margaret is developing a Faculty Development for Global Health Fellowship. This presentation will discuss the development of a global health curriculum in collaboration with a well established faculty development fellowship. It will review recently developed competencies for global health fellows and those specific to this program. This presentation will also examine evaluation techniques used to measure the impact of current fellowships and focus on newly developed tools specific for this program.
• Campbell, A. M., Coley, K., Corbo, J., Breslin, T., Thorpe, C., Klatt, P., Cox-Vance, L., McGivney, M. S., Zaharoff, J., & Sakely, H. (2015, April). What is the Impact of Pharmacists within a Patient Care Practice in Identifying, Resolving, and Preventing Drug Therapy Problems? A Subset of the PIVOTS (Pharmacist-led Interventions on Transitions of Seniors) Group. Society of Teachers of Family Medicine Annual Spring Conference. Orlando, Florida: ASHP Research and Education Foundation, Jewish Healthcare Foundation.
  More info

  Drug therapy problems (DTPs) in older adults occur frequently and are considered to have a significant negative impact on their health outcomes if not identified, resolved, and prevented. By providing continuous comprehensive medication management, pharmacists are able to address drug therapy problems and facilitate more seamless transitions. Two pharmacists have been integrated into an geriatric interprofessional team at all care levels of care (eg, inpatient, outpatient physician office, skilled nursing facility) within the University of Pittsburgh Medical Center. The objective of this study is to quantify the impact of pharmacists on the care of older adults by describing the most common DTPs identified by pharmacists, medications involved, the actions taken to resolve DTPs, the 90-day impact of DTP resolution, as well as comparing and contrasting DTPs identified across the continuum of care over a 6-month period.
• Campbell, A. M., Joseph, M., & Payette, N. (2015, April). You're Taking What?. Society of Teachers of Family Medicine Annual Spring Conference. Orlando, Florida.
  More info

  Eighteen percent of patients in the United States report using at least one complementary or alternative medication (CAM) yearly, and the majority do not disclose this information to their health care providers (Eisenberg). CAM are pharmacologically active substances that, in addition to their reported benefits, also have adverse effects and can interact with conventional medication. Without monitoring, certain natural products can decrease the therapeutic effect of conventional medication, can precipitate bleeding, and can cause other toxic effects. Participants will be able to assess patients’ use of CAM, list useful resources about complementary medication, and better apply basic information about commonly used CAM. Increased comfort with CAM will enhance participants’ ability to care for patients and teach medical students and residents.

Poster Presentations

• Doe, E., Mehrara, M., Mirzakandov, M., & Campbell, A. M. (2025, May).

  Practicing pharmacists' knowledge and comfortability with geriatric pharmacy

  . University of Arizona R. Ken Coit College of Pharmacy Poster Event. Virtual.
• Craig, P., Sisk, G., Osborn, K., Etim, S., Kennedy, A. K., & Campbell, A. M. (2024, December). Exploring professional, patient, and student perceptions of innovative pharmacist roles in non-traditional settings. American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting. New Orleans, LA.
• DeLellis, T., Sadowski, C., Noureldin, M., Coe, A., Olatunde, O. A., Campbell, A. M., Nagy, M., Clifford, K., Sharma, M., & Freire-Cobo, C. (2024, July 2024). State of the academic pharmacy workforce specializing in geriatrics. AACP Annual Meeting. Boston, MA.
• Sadowski, C., Noureldin, M., Coe, A., Olatunde, O. A., Campbell, A. M., DeLellis, T., Nagy, M., Clifford, K., Sharma, M., & Freire-Cobo, C. (2024, June 2024). State of the academic pharmacy workforce specializing in geriatrics. Canadian Pharmacy Education and Research Conference (CPERC). Quebec City, QC.
• Campbell, A. M., Antwi, P. B., Davis, L., & Warholak, T. L. (2023, July). Fixed versus random weekly team assignments and student outcomes in a therapeutics course. American Association of Colleges of Pharmacy Annual Meeting. Aurora, CO.
• Sadowski, C., Coe, A., Campbell, A. M., Olatunde, O. A., DeLellis, T., Nagy, M., & Noureldin, M. (2023, May). State of the Academic Pharmacy Workforce Specializing in Geriatrics. American Geriatrics Society Annual Scientific Meeting. Long Beach, CA.
• Sedo, H., Campbell, A. M., & Kennedy, A. K. (2023). Describing Anticholinergic Burden in Patients with Mild Cognitive Impairment or Dementia. American Pharmacists Association Annual Meeting. Phoenix, AZ.
• Campbell, A. M., Pae, E., Lee, E., Price, A., Jacisin, T., & DeAngelo, J. (2022, May). Outcomes Associated With Inappropriately Dose-Reduced Apixaban in Older Adults With Atrial Fibrillation. American Geriatrics Society Annual Scientific Meeting. Orlando, FL.
• Campbell, A. M., Pae, E., Lee, E., Price, A., Jacisin, T., & DeAngelo, J. (2022, May). Outcomes Associated With Inappropriately Dose-Reduced Apixaban in Older Adults With Atrial Fibrillation. United States Deprescribing Network (USDeN) Annual Meeting. Orlando, FL.
• Bondugji, D. A., Nguyen, T. M., Hegazy, S. M., Martin, J. R., & Campbell, A. M. (2019, December 2019). Topical melatonin, resveratrol, and rapamycin for skin anti-aging: a systematic review. ASHP Midyear Clinical Meeting. Las Vegas, NV.
• Marupuru, S., Campbell, A. M., & Lee, J. K. (2019, Spring 2019). Use of Melatonin Receptor Agonists for the Treatment of Insomnia in Older Adults: A Systematic Review and Meta-Analysis. 2019 University of Arizona Student Showcase Research Forum. University of Arizona.
  More info

  Srujitha Marupuru (graduate student) won the following awards for this poster:• Winner of Katheryne B. Willock Library Research Award ($1,000)• 1st place in best Human Health Research Award ($750)
• Weygint, A., Lee, J. K., & Campbell, A. M. (2019, November). ASCP at the University of Arizona.. American Society of Consultant Pharmacists Annual Meeting. Grapevine, TX: American Society of Consultant Pharmacists.
• Campbell, A. M., Axon, D. R., Slack, M., Martin, J. R., & Lee, J. K. (2018, Spring 2018). Melatonin for Prevention of Postoperative Delirium in Older Adults: A Systematic Review and Meta-Analysis. American Geriatrics Society. Orlando, FL.
• Droopad, D., Shepard, D., Shah, I., & Campbell, A. M. (2018, December). Risk of Thromboembolic and Bleeding Events in Post-Operative Hip Fracture Patients Receiving Aspirin or Enoxaparin for VTE Prophylaxis. ASHP Midyear Clinical Meeting. Anaheim, CA.
• Marupuru, S., Campbell, A. M., & Lee, J. K. (2018, Fall). Melatonin and Melatonin Receptor Agonists for the Treatment of Insomnia in Older Adults: A Systematic Review and Meta-Analysis. American College of Clinical Pharmacy Annual Meeting. Seattle, WA.
• Ng, Y., Mejia, T., Hiller, A., DeAngelo, J., & Campbell, A. M. (2018, October). Prescribing Practices of Apixaban in Older Adults. American College of Clinical Pharmacy Annual Meeting. Seattle, WA.
• Campbell, A. M., & Erstad, B. L. (2017, May). Tapering Regimens Following Medium to High Dose Extended Duration Corticosteroid Monotherapy in Adults with Rheumatic Disease: A Systematic Review. ACCP Virtual Poster Symposium.
• Campbell, A. M., Goldstone, L. W., Slack, M. K., Zehri, S., Frent, A., & Isemede, O. (2017, Spring). The Association Between Factors Related to Vitamin D and Depression in Future Pharmacists. College of Psychiatric and Neurologic Pharmacists (CPNP) Annual Meeting. Phoenix, AZ.
• Isemede, O., Zehri, S., Frent, A., Slack, M. K., & Campbell, A. M. (2017, December). The Association Between Factors Related to Vitamin D and Depression in Future Pharmacists. ASHP Midyear Clinical Meeting. Orlando, FL.
• Raheem, F., Soontornprueska, S., Campbell, A. M., & Weibel, J. (2017, December 2017). Utilization of electronic order sets based on the Center for Disease Control’s Surviving Sepsis Campaign guidelines in a community hospital. ASHP Midyear Clinical Meeting. Orlando, FL.
• Vraney, J., Oman, N., Xie, C., Erstad, B., & Campbell, A. M. (2017, December 2017). Oseltamivir Prescribing Practices for Influenza Patients in the Intensive Care Unit and Associated Outcomes. ASHP Midyear Clinical Meeting. Orlando, FL.
• Campbell, A. M., Coley, K., Corbo, J., Joseph, M., DeLellis, T., Higbea, A., Payette, N., Haver, A., Cox-Vance, L., Thorpe, C., McGivney, M. S., Klatt, P., Zaharoff, J., & Sakely, H. (2016, May). Outcomes of coordinated, pharmacist-led, anticoagulation management of older adults across the levels of care: A mixed methods analysis of the PIVOTS model. American Geriatrics Society Annual Meeting. Long Beach, California.
• Campbell, A. M., Coley, K., Thorpe, C., Corbo, J., McGivney, M. S., Klatt, P., Zaharoff, J., Cox-Vance, L., & Sakely, H. (2016, May 2016). The Impact of Pharmacists on the Identification, Resolution, and Prevention of Drug Therapy Problems in Geriatric Patients Across the Healthcare Continuum: A Subset of the PIVOTS Group. Pennsylvania Academy of Family Physicians Research Day. Pittsburgh, PA.
• DeLellis, T., Campbell, A. M., & Sakely, H. (2016, May 2016). Implementation of an interprofessionally developed hypoglycemic protocol in a skilled nursing facility. American Geriatrics Society Annual Meeting. Long Beach, California.

Creative Performances

• Edwards, C., Bridges, A., Campbell, A. M., Schnellmann, R., & Naderi, M. (2020. The Big, Ugly Pandemic in the Room. PharmCAST PodcastUniversity of Arizona College of Pharmacy. https://anchor.fm/pharmcast

Other Teaching Materials

• Campbell, A. M. (2023. Pharmacist Perspective for MED 101: Introduction to Medicine. University of Arizona College of Medicine.